News:   •  Restaurants   •  Library Catalog   •  Library Activities  •  History   •  Facebook / Twitter / RSS

Monrovia's Staar Surgical Expects 37% Annual Growth; 42% Growth for Last Quarter

Monrovia's STAAR Surgical, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, estimates its sales for its fourth quarter - which ended December 28, 2018 - will have increased approximately 42% over the same period for 2017. Total net sales for the fourth quarter are expected to be approximately $31.2 million and total net sales for fiscal 2018 are expected to be approximately $124.0 million, representing approximately 37% growth over fiscal 2017.

- Brad Haugaard

No comments:

Post a Comment